176 results
Page 4 of 9
8-K
EX-99.1
68aqvt304fro
6 May 21
Adaptimmune Reports First Quarter Financial Results and Business Update
7:38am
8-K
EX-99.1
e7u4wwhp3y659vj1
25 Feb 21
Adaptimmune Reports Fourth Quarter / Full Year 2020 Financial Results and Business Update
7:37am
8-K
EX-10.1
bzvmg dvppq4
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
8-K
EX-99.1
irixv3oz77vb30mkcc6s
20 Nov 20
Regulation FD Disclosure
7:36am
S-3ASR
EX-23.1
elr cfriv6twqh3obwip
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
9plz10efz
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-1.2
ukffu44a
10 Aug 20
Automatic shelf registration
5:01pm
424B5
axh27biss48xac
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-1.1
7gwbk
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
fi90vhkj yf2
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-99.1
krmah9i1fdz lkvb4n
14 May 20
Adaptimmune Reports Q1 Financial Results
7:37am